Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy
Public ClinicalTrials.gov record NCT01675947. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-Center, Randomized, Single Masked Phase 2 Study of Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration
Study identification
- NCT ID
- NCT01675947
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Eye Institute (NEI)
- NIH
- Enrollment
- 52 participants
Conditions and interventions
Conditions
Interventions
- Sirolimus Drug
- Lidocaine Drug
Drug
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2012
- Primary completion
- May 31, 2015
- Completion
- Jan 31, 2016
- Last update posted
- Dec 9, 2015
2012 – 2016
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Loma Linda University | Loma Linda | California | 92354 | — |
| University of California, Davis | Sacramento | California | 95817 | — |
| University of Florida HSC | Jacksonville | Florida | 32209 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| University of Illinois | Chicago | Illinois | 60612 | — |
| Elman Retina Group | Baltimore | Maryland | 21237 | — |
| Vision Research Foundation | Grand Rapids | Michigan | 49546 | — |
| Charlotte Eye Ear Nose & Throat Associates | Charlotte | North Carolina | 28210 | — |
| Scheie Eye Institute, University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Palmetto Retina Center | West Columbia | South Carolina | 29169 | — |
| Southeastern Retina Associates, P.C. | Knoxville | Tennessee | 37909 | — |
| Texas Retina Associates | Dallas | Texas | 75231 | — |
| University of Wisconsin | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01675947, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 9, 2015 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01675947 live on ClinicalTrials.gov.